Oral finasteride (1 mg) reduces serum DHT by 60–70% and scalp DHT by roughly 40–60%. Topical finasteride lowers scalp DHT by a comparable amount but only reduces serum DHT by about 25–35%—meaning far less systemic exposure. Both deliver similar regrowth outcomes in clinical trials.
If you’ve been researching hair regrowth treatments, you’ve probably seen the claim that “finasteride reduces DHT by 70%.” That number is real, but it’s only part of the picture. The full story depends on whether you’re taking oral or topical finasteride, whether we’re talking about serum (blood) DHT or scalp (tissue) DHT, and what dosage you’re using.
This article breaks down the exact percentages from published clinical trials so you can understand precisely what each form of finasteride does to your DHT levels—and what that means for your regrowth protocol.
Understanding DHT: Serum vs. Scalp
Before diving into percentages, you need to understand the difference between two types of DHT measurement. They’re often conflated, but they tell very different stories.
Serum DHT is the DHT circulating in your bloodstream. This is easy to measure with a standard blood draw, which is why most clinical trial data reports serum levels. When someone says “finasteride reduces DHT by 70%,” they’re usually talking about serum DHT.
Scalp DHT is the DHT present in your actual hair follicle tissue. This is what directly miniaturizes your follicles and drives androgenetic alopecia. It’s harder to measure (requires scalp biopsies), so less data exists, but it’s the number that actually matters for your hair.
A treatment could slash serum DHT by 70% while only reducing scalp DHT by 40%—or it could barely touch serum DHT while still hitting scalp DHT hard. This is exactly the dynamic that makes topical finasteride so interesting.
Oral Finasteride: The Numbers
Oral finasteride at the standard 1 mg dose has been studied extensively since its FDA approval in 1997. The DHT reduction data is remarkably consistent across trials.
(biopsy-confirmed)
Serum DHT Reduction by Dose
The relationship between oral finasteride dosage and serum DHT suppression is dose-dependent but nonlinear. You don’t get double the suppression from double the dose.
| Dose | Serum DHT Reduction | Notes |
|---|---|---|
| 0.2 mg/day | ~50% | Used in some Japanese protocols |
| 0.5 mg/day | ~60% | Common “low dose” approach |
| 1 mg/day | ~65–70% | FDA-approved dose for hair (Propecia) |
| 5 mg/day | ~70–75% | BPH dose (Proscar) – marginal extra benefit |
Notice the diminishing returns: going from 1 mg to 5 mg barely moves the needle on DHT suppression but substantially increases the drug’s systemic presence. This is why dermatologists almost universally prescribe 1 mg for androgenetic alopecia rather than the higher BPH dose.
Scalp Tissue DHT
A landmark study by Drake et al. measured scalp DHT directly via biopsy in men taking 1 mg finasteride daily. After 42 days, scalp DHT was reduced by approximately 64% compared to baseline. Other studies have reported scalp DHT reductions ranging from 40% to 60%, depending on the measurement methodology and timing.
The takeaway: oral finasteride doesn’t just lower blood DHT—it significantly reduces DHT at the follicle level, which is what drives clinical regrowth results.
Topical Finasteride: Targeted DHT Suppression
Topical finasteride has emerged as a compelling alternative for men who want scalp-level DHT suppression with minimal systemic exposure. The data here is newer but increasingly robust.
The Key Phase III Data
The most cited comparison comes from a randomized controlled trial comparing topical finasteride (0.25% solution) to oral finasteride (1 mg). The results at 24 weeks:
| Measurement | Oral Finasteride (1 mg) | Topical Finasteride (0.25%) |
|---|---|---|
| Serum DHT reduction | ~55–70% | ~25–35% |
| Scalp DHT reduction | ~40–60% | ~30–50% |
| Hair count increase | Comparable | Comparable |
| Systemic exposure | Full systemic | Significantly lower |
The critical finding: topical finasteride achieved comparable hair regrowth results despite only reducing serum DHT by about half as much as the oral form. This makes biological sense—serum DHT reduction is a side effect of oral dosing, not the mechanism of action. The drug works by blocking the 5-alpha-reductase enzyme in the scalp, and topical application concentrates it exactly where it needs to be.
Since most finasteride side effects are thought to correlate with systemic DHT suppression (serum levels), the lower serum DHT impact of topical finasteride may translate to a lower side-effect profile. Studies have shown reduced incidence of sexual side effects with topical vs. oral formulations, though more long-term data is needed.
Topical Finasteride Systemic Absorption
One of the most common questions: does topical finasteride stay in your scalp, or does it go systemic?
The honest answer is that some systemic absorption does occur with topical finasteride. The 25–35% serum DHT reduction confirms this. However, that level of systemic absorption is roughly half of what oral finasteride produces. The exact amount varies based on the vehicle (spray vs. solution vs. gel), concentration, and individual absorption characteristics.
Several compounding pharmacies now offer formulations specifically designed to maximize scalp penetration while minimizing systemic absorption, using vehicles that enhance follicular delivery.
DHT Reduction Timeline
DHT suppression doesn’t happen overnight. Here’s what to expect:
| Timeframe | Oral Finasteride | Topical Finasteride |
|---|---|---|
| 24 hours | ~65% serum DHT reduction | Localized scalp suppression begins |
| 1 week | Near-maximum serum suppression | Steady-state scalp levels building |
| 1–3 months | Full tissue-level effects | Full tissue-level effects |
| 3–6 months | Visible regrowth beginning | Visible regrowth beginning |
| 12+ months | Maximum clinical benefit | Maximum clinical benefit |
The fast serum response is why blood tests taken shortly after starting finasteride will show dramatic DHT drops. But don’t confuse blood levels with hair results—your follicles need months of sustained reduced DHT exposure to shift from miniaturization back to healthy terminal growth.
Oral vs. Topical: Which Reduces DHT “Better”?
If your only metric is raw serum DHT suppression, oral finasteride wins easily (65–70% vs. 25–35%). But that’s the wrong metric.
The right question is: which form reduces DHT where it matters (the scalp) while minimizing DHT reduction where it doesn’t (everywhere else)?
By that standard, topical finasteride has a more favorable ratio. It achieves comparable scalp DHT reduction and comparable clinical regrowth with roughly half the systemic DHT impact. For men concerned about potential systemic side effects, that’s a meaningful advantage.
For men who tolerate oral finasteride well and want maximum simplicity (swallow a pill once daily), oral remains the gold standard with 25+ years of safety data behind it.
Get a Personalized DHT-Blocking Protocol
Both oral and topical finasteride require a prescription. Telehealth platforms make it easy to consult a provider and get started from home.
Explore Topical Finasteride Options →Does More DHT Reduction Mean More Hair?
Not necessarily. The dose-response curve for DHT suppression and hair regrowth is not linear. Multiple studies have shown that once you cross a threshold of roughly 40–50% scalp DHT suppression, additional suppression yields diminishing returns for hair count.
This explains several real-world observations. Men on 0.5 mg finasteride often see results comparable to men on 1 mg, despite measurably different serum DHT levels. And men who switch from oral to topical finasteride—dropping their serum DHT reduction significantly—often maintain their hair gains, because scalp-level suppression remains adequate.
Dutasteride: The 90%+ Option
For completeness: dutasteride (0.5 mg daily) inhibits both Type I and Type II 5-alpha-reductase, reducing serum DHT by approximately 90–95%. That’s significantly more than finasteride’s 65–70%.
However, dutasteride is not FDA-approved for androgenetic alopecia in the United States (it is approved in some other countries, including South Korea and Japan). Some dermatologists prescribe it off-label for men who don’t respond adequately to finasteride. The clinical trials show modestly superior hair count improvements with dutasteride vs. finasteride, consistent with the greater DHT suppression.
Stacking: Finasteride + Minoxidil
DHT reduction is only one axis of a regrowth protocol. The “Big 3” protocol combines finasteride (DHT suppression) with minoxidil (growth stimulation) and ketoconazole shampoo (anti-inflammatory/mild anti-androgen). The combination outperforms any single treatment because the mechanisms are complementary, not redundant.
Minoxidil doesn’t affect DHT levels at all—it works by prolonging the anagen (growth) phase and enhancing blood flow to follicles. So even if your finasteride only reduces scalp DHT by 40%, adding minoxidil gives your follicles a second, independent growth signal.
Don’t get fixated on hitting a specific DHT number. The goal isn’t to drive DHT to zero (your body needs some DHT). The goal is to reduce scalp DHT enough to halt miniaturization and allow regrowth. Both oral and topical finasteride achieve this for the majority of men.
Where to Get Finasteride
Finasteride is a prescription medication in most countries. The most convenient way to start is through a telehealth platform that specializes in hair regrowth protocols:
| Platform | Oral Finasteride | Topical Finasteride | Starting Price |
|---|---|---|---|
| Happy Head | ✓ | ✓ (custom compound) | $49/mo |
| Strut Health | ✓ | ✓ (custom compound) | $55/mo |
| Sesame Care | ✓ | — | $29 consult |
Ready to Start Your Protocol?
Get a personalized prescription—oral or topical—from a licensed dermatology provider. No waiting room required.
Compare Providers →